Skip to main content
Premium Trial:

Request an Annual Quote

David Altshuler

CRISPR Therapeutics has added David Altshuler to its Board of Directors, where he will hold an observer seat. Altshuler is Executive VP of Global Research and CSO at Vertex Pharmaceuticals. He joins the board following Vertex's acquisition of an ownership stake in CRISPR Therapeutics.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.